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A B S T R A C T
Epstein–Barr virus (EBV) is known to be one of the causes of viral hepatitis, but its association with
cholecystitis is known to be rare. Cholestasis by EBV-induced hepatitis might be a cause of acute
cholecystitis in all of the recently reported cases. In contrast, we experienced the case of a 20-year-old
woman who was infected with EBV and presented with acute cholecystitis without cholestasis.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Infection with the Epstein–Barr virus (EBV) during childhood is
mainly asymptomatic, whereas infectious mononucleosis with
clinical signs such as fever, pharyngitis, lymphadenopathy,
hepatosplenomegaly, and hepatocellular dysfunction occurs in
at least 50% of adolescents and adults with primary infection.1
Hepatic involvement of EBV is common and elevations of
aminotransferases are up to 96%.2 However, gallbladder involve-
ment is rare, and cases with acute cholecystitis have only been
reported four times in the recent two years in Europe;3–6 all of
these cases have been closely related with cholestasis. We report
herein a case of acute cholecystitis without cholestasis by EBV
infection.
2. Case report
A previously healthy, 20-year-old woman was admitted with a
5-day history of fever and sore throat. She had a poor appetite,
abdominal pain, and vomiting 3 days ago. On admission, she was
ill-looking and her blood pressure was 90/60mmHg, pulse rate 70/
min, respiration rate 20/min, and body temperature 38.3 8C. On
physical examination, the patient’s tonsil and pharynx were
hyperemic and swollen. The anterior cervical lymph nodes were
enlarged bilaterally and tender. On examination of the abdomen,
she had tenderness in the right upper quadrant and Murphy’s sign* Corresponding author. Tel.: +82 2 2224 2693; fax: +82 2 478 6925.
E-mail address: helppl@hallym.ac.kr (J.S. Eom).
1201-9712/$36.00 – see front matter  2009 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.06.004was positive. The liver and spleenwere enlarged and palpable 2 cm
under the costal margin.
Laboratory ﬁndings on admission showed a white blood cell
count of 10.2  109/l (13.5% neutrophils, 70% lymphocytes),
aspartate aminotransferase (AST) 171 IU/l, alanine aminotransfer-
ase (ALT) 299 IU/l, alkaline phosphatase 727 IU/l, gamma-
glutamyltransferase 202 IU/l, total bilirubin 0.7 mg/dl, and lactate
dehydrogenase 519 IU/l. AST and ALT increased to 229 IU/l and 281
IU/l, respectively, on day 5, but decreased to under the upper limit
of reference value.
Plain radiologic studies did not show any abnormalities.
Abdominal computed tomography showed a severe degree of
hepatosplenomegaly and diffuse edematous changes of the
gallbladder wall with mucosal enhancement and without stones
or dilatation of the biliary tract, which was compatible with acute
cholecystitis (Figure 1).
In consultation with the surgical department, it was decided to
observe her clinical course. Since we suspected the possibility of
EBV infection, heterophil antibodies and EBV markers were
examined. IgM antibody against Epstein–Barr virus capsid antigen
(VCA) was positive, but IgG antibody for Epstein–Barr nuclear
antigen (EBNA) was negative and other serologic markers were
negative. Extensive laboratory evaluation ruled out hepatitis A, B
and C viruses and other possible infectious agents.
We started intravascular hydration and intravenous injection of
amoxicillin/clavulanic acid, but stopped administration of anti-
biotics because there was no evidence of bacterial infection. She
became afebrile after the second hospital day. Nausea, vomiting
and throat pain subsided after hydration on the third hospital day.
Physically, abdominal tenderness had completely subsided on theses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Computed tomography showing diffuse edematous change with mucosal
enhancement of the gallbladder wall.
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discharge her, in good condition without any complaint.
3. Discussion
EBV is known to be one of the causes of viral hepatitis, but its
association with cholecystitis is known to be rare. The diagnosis of
acute cholecystitis is based on clinical and/or radiological ﬁndings,
whereas acute EBV infection is conﬁrmed serologically. Therefore,
it is difﬁcult for clinicians to be aware of the possible involvement
of the gallbladder and to conﬁrm EBV infection as the origin of
acute cholecystitis.
Isolated thickening of the gallbladder wall has been described
during the course of mononucleosis syndromes and it has been
proposed as a sign of the severity of the illness.7 However, acute
cholecystitis by EBV has only been reported four times in the
recent two years in Europe.3–6 All of the cases occurred in Europe
(two cases in Greece, one case in the Netherlands, and one case in
Italy) and all of themwere female. Cholestatic hepatitis was shown
in all of these cases, with elevated bilirubin. In these cases, acutecholecystitis was considered as a complication of a severe systemic
inﬂammation and bile stasis was also implicated as one of the
probable mechanisms resulting in gallbladder inﬂammation.8
EBV-induced hepatitis has recently been recognized as an
important cause of cholestasis, but, in our case, bilirubin levels
were within the reference range during hospitalization. Further-
more, our patient had signs and symptoms compatible with acute
cholecystitis from the early stage. Hence, we could presume it is
possible that the pathogenetic mechanism in our case was the
direct invasion of the gallbladder. We could not conﬁrm the direct
invasion of the gallbladder by EBV in our case, but it is possible
because such amechanism has been documented byMourani et al.
in a case of acute cholecystitis due to viral hepatitis A.9
We experienced the ﬁrst case of acute cholecystitis occurring in
the course of primary EBV infection without cholestasis in Korea,
and this EBV-associated acute cholecystitis was treated conserva-
tively without surgical intervention.
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